Results 261 to 270 of about 5,690,964 (274)

BreastWatch: A Varian Eclipse script tool for Community‐Based automatic evaluation of breast treatment plans

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect and improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose‐constraints enhanced by a Community‐Based approach.
Stefano Agostinelli, Daniele Zefiro, Stefania Garelli, Francesca Cavagnetto, Marco Gusinu, Monica Bevegni, Gladys Blandino, Alessandra Fozza, Fabrizio Levrero   +8 more
wiley   +1 more source

Surface dose analysis and dosimetric comparison of Halcyon versus Truebeam in breast cancer radiotherapy: An OSL dosimetry study

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Breast cancer is a neoplastic disease with high prevalence among women. Radiotherapy is one of the principal treatment modalities for this disease, but it poses significant challenges. This study aimed to compare and evaluate the technical and dosimetric performance of conventional C‐arm linac systems and a new design, Halcyon, in the ...
Mustafa Çağlar, Kudret Akçay, Esra Serin, Dursun Eşitmez, Mehmet Sıddık Cebe, Navid Kheradmand, Ömer Yazıcı, Dilek Ünal, Evrim Metcalfe   +8 more
wiley   +1 more source

Comprehensive clinical evaluation of novel 4DCT‐based lung function imaging methods

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Methods have been developed that apply image processing to 4DCTs to generate 4DCT‐ventilation/perfusion lung imaging. Traditional methods for 4DCT‐ventilation rely on Hounsfield‐Unit (HU) density‐change methods and suffer from poor numerical robustness while not providing 4DCT‐perfusion data.
Ehsan Golkar, Taindra Neupane, Lydia Wilson, Jennifer Kwak, Richard Castillo, Edward Castillo, Yevgeniy Vinogradskiy   +6 more
wiley   +1 more source

An extension to the OVH concept for knowledge‐based dose volume histogram prediction in lung tumor volumetric‐modulated arc therapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Volumetric‐modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs‐at‐risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment
Johann Brand, Juliane Szkitsak, Oliver J. Ott, Christoph Bert, Stefan Speer   +4 more
wiley   +1 more source

Design and validation of a novel dosimetry phantom for motion management audits

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background We present a novel phantom design for conducting end‐to‐end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion‐included) and the dose delivered to the time‐averaged ...
Alex Burton, Sabeena Beveridge, Nicholas Hardcastle, Silvio Malfitana, Janaka Madamperuma, Rick Franich   +5 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment ...
D. Ettinger, D. Wood, D. Aisner, W. Akerley, J. Bauman, Ankit Bharat, D. Bruno, Joe Y. Chang, L. Chirieac, T. D’amico, M. Decamp, T. Dilling, J. Dowell, S. Gettinger, T. Grotz, M. Gubens, A. Hegde, R. Lackner, M. Lanuti, Jules Lin, B. Loo, C. Lovly, F. Maldonado, E. Massarelli, D. Morgensztern, T. Ng, G. Otterson, J. Pacheco, S. Patel, Gregory Riely, J. Riess, S. Schild, T. Shapiro, Aditi P. Singh, J. Stevenson, A. Tam, T. Tanvetyanon, J. Yanagawa, Stephen C. Yang, E. Yau, K. Gregory, M. Hughes   +41 more
semanticscholar   +1 more source

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Science, 2007
The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.
J. Engelman, K. Zejnullahu, T. Mitsudomi, Youngchul Song, Courtney Hyland, Joon-Oh Park, N. Lindeman, Christopher-Michael Gale, Xiaojun Zhao, J. Christensen, T. Kosaka, A. Holmes, A. Rogers, F. Cappuzzo, T. Mok, Charles Lee, B. Johnson, L. Cantley, P. Jänne   +18 more
semanticscholar   +1 more source

Revisions in the International System for Staging Lung Cancer.

Chest, 1997
Revisions in stage grouping of the TNM subsets (T=primary tumor, N=regional lymph nodes, M=distant metastasis) in the International System for Staging Lung Cancer have been adopted by the American Joint Committee on Cancer and the Union Internationale ...
C. Mountain
semanticscholar   +1 more source

The global burden of lung cancer: current status and future trends

Nature Reviews Clinical Oncology, 2023
A. Leiter, R. Veluswamy, J. Wisnivesky
semanticscholar   +1 more source

The biology and management of non-small cell lung cancer

Nature, 2018
R. Herbst, D. Morgensztern, C. Boshoff
semanticscholar   +1 more source